New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Low-dose radiotherapy boost helps prevent local recurrence with better cosmetic outcomes in young breast cancer patients

Low-dose radiotherapy boost helps prevent local recurrence with better cosmetic outcomes in young breast cancer patients

by European Organisation for Research and Treatment of CancerThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Ima
Oncology March 30,2024
Low-dose radiotherapy boost helps prevent local recurrence with better cosmetic outcomes in young breast cancer patients

Low-dose radiotherapy boost helps prevent local recurrence with better cosmetic outcomes in young breast cancer patients

by European Organisation for Research and Treatment of CancerThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Ima
Oncology March 30,2024
Exercise shown to help patients with advanced breast cancer, especially if they are suffering with pain

Exercise shown to help patients with advanced breast cancer, especially if they are suffering with pain

by European Organisation for Research and Treatment of CancerA patient exercising as part of the clinical trial. Credit: EORTC / Anouk HienschTaking part in an exercise program reduced pain and fatigu
Oncology March 30,2024
Exercise shown to help patients with advanced breast cancer, especially if they are suffering with pain

Exercise shown to help patients with advanced breast cancer, especially if they are suffering with pain

by European Organisation for Research and Treatment of CancerA patient exercising as part of the clinical trial. Credit: EORTC / Anouk HienschTaking part in an exercise program reduced pain and fatigu
Oncology March 30,2024
Predicting infection risk in childhood cancer

Predicting infection risk in childhood cancer

by Olivia Dimmer,Northwestern UniversityCredit: CC0 Public DomainA statistical model can accurately predict the risk of bloodstream infections in a subset of children with cancer, according to a
Oncology March 30,2024
Predicting infection risk in childhood cancer

Predicting infection risk in childhood cancer

by Olivia Dimmer,Northwestern UniversityCredit: CC0 Public DomainA statistical model can accurately predict the risk of bloodstream infections in a subset of children with cancer, according to a
Oncology March 30,2024
FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T
Oncology March 30,2024
FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T
Oncology March 30,2024
New study shows association of historical housing discrimination and shortfalls in colon cancer treatment

New study shows association of historical housing discrimination and shortfalls in colon cancer treatment

by Jeff Hansen,University of Alabama at BirminghamMap of redlining in Birmingham, 1933. Credit: Public domain, Wikimedia CommonsA nationwide study of 196 cities shows that housing discrimination
Oncology March 30,2024
New study shows association of historical housing discrimination and shortfalls in colon cancer treatment

New study shows association of historical housing discrimination and shortfalls in colon cancer treatment

by Jeff Hansen,University of Alabama at BirminghamMap of redlining in Birmingham, 1933. Credit: Public domain, Wikimedia CommonsA nationwide study of 196 cities shows that housing discrimination
Oncology March 30,2024
Discovery suggests new strategy against follicular lymphoma

Discovery suggests new strategy against follicular lymphoma

byWeill Cornell Medical CollegeGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.02.010A team led by researchers at Weill Cornell Medicine has identified import
Oncology March 30,2024
Discovery suggests new strategy against follicular lymphoma

Discovery suggests new strategy against follicular lymphoma

byWeill Cornell Medical CollegeGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.02.010A team led by researchers at Weill Cornell Medicine has identified import
Oncology March 30,2024
A combined PET-MRI scan could improve treatment for patients with early breast cancer

A combined PET-MRI scan could improve treatment for patients with early breast cancer

by European Organisation for Research and Treatment of CancerPhoto of researchers Dr. Rosa Di Micco & Professor Oreste Gentilini. Credit: EORTC / Rosa Di MiccoUsing a combined scanning technique o
Oncology March 30,2024
A combined PET-MRI scan could improve treatment for patients with early breast cancer

A combined PET-MRI scan could improve treatment for patients with early breast cancer

by European Organisation for Research and Treatment of CancerPhoto of researchers Dr. Rosa Di Micco & Professor Oreste Gentilini. Credit: EORTC / Rosa Di MiccoUsing a combined scanning technique o
Oncology March 30,2024
Researchers demonstrate technique for identifying single cancer cells in blood for the first time

Researchers demonstrate technique for identifying single cancer cells in blood for the first time

byKeele UniversityBrightfield image of a cytospun sample containing PBMC and individual CALU-1 cancer cells. Credit:PLOS ONE(2023). DOI: 10.1371/journal.pone.0289824A pioneering stud
Oncology March 30,2024
Researchers demonstrate technique for identifying single cancer cells in blood for the first time

Researchers demonstrate technique for identifying single cancer cells in blood for the first time

byKeele UniversityBrightfield image of a cytospun sample containing PBMC and individual CALU-1 cancer cells. Credit:PLOS ONE(2023). DOI: 10.1371/journal.pone.0289824A pioneering stud
Oncology March 30,2024
Unveiling gender differences in cancer: New insights into genomic instability

Unveiling gender differences in cancer: New insights into genomic instability

by Health Data ScienceScientists from Peking University Health Science Center investigated sex differences in genome instability across 16 cancer types, identifying male-biased and female-biased copy
Oncology March 30,2024
Unveiling gender differences in cancer: New insights into genomic instability

Unveiling gender differences in cancer: New insights into genomic instability

by Health Data ScienceScientists from Peking University Health Science Center investigated sex differences in genome instability across 16 cancer types, identifying male-biased and female-biased copy
Oncology March 30,2024
Exploring ferroptosis and its implications in lung cancer

Exploring ferroptosis and its implications in lung cancer

by Cactus CommunicationsEven with advances in diagnosis and treatments, the survival rate of patients with lung cancer, remains to be low. Ferroptosis is a type of iron-dependent programmed cell death
Oncology March 30,2024
Exploring ferroptosis and its implications in lung cancer

Exploring ferroptosis and its implications in lung cancer

by Cactus CommunicationsEven with advances in diagnosis and treatments, the survival rate of patients with lung cancer, remains to be low. Ferroptosis is a type of iron-dependent programmed cell death
Oncology March 30,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com